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ABSTRACT The alternative sigma factor s 54 has been shown to regulate the expression
of a wide array of virulence-associated genes, as well as central metabolism, in bacterial
pathogens. In Gram-positive organisms, the s 54 is commonly associated with carbon me-
tabolism. In this study, we show that the Enterococcus faecalis alternative sigma factor
s54 (RpoN) and its cognate enhancer binding protein MptR are essential for mannose
utilization and are primary contributors to glucose uptake through the Mpt phospho-
transferase system. To gain further insight into how RpoN contributes to global transcrip-
tional changes, we performed microarray transcriptional analysis of strain V583 and an
isogenic rpoN mutant grown in a chemically defined medium with glucose as the sole
carbon source. Transcripts of 340 genes were differentially affected in the rpoN mutant;
the predicted functions of these genes mainly related to nutrient acquisition. These dif-
ferentially expressed genes included those with predicted catabolite-responsive element
(cre) sites, consistent with loss of repression by the major carbon catabolite repressor
CcpA. To determine if the inability to efficiently metabolize glucose/mannose affected
infection outcome, we utilized two distinct infection models. We found that the rpoN
mutant is significantly attenuated in both rabbit endocarditis and murine catheter-associ-
ated urinary tract infection (CAUTI). Here, we examined a ccpA mutant in the CAUTI
model and showed that the absence of carbon catabolite control also significantly
attenuates bacterial tissue burden in this model. Our data highlight the contribution of
central carbon metabolism to growth of E. faecalis at various sites of infection.
IMPORTANCE Hospital-acquired infections account for 2 billion dollars annually in
increased health care expenses and cause more than 100,000 deaths in the United
States alone. Enterococci are the second leading cause of hospital-acquired infections.
They form biofilms at surgical sites and are often associated with infections of the uri-
nary tract following catheterization. Nutrient uptake and growth are key factors that
influence their ability to cause disease. Our research identified a large set of genes that
illuminate nutrient uptake pathways in enterococci. Perturbation of the metabolic circuit
reduces virulence in a rabbit endocarditis model, as well as in catheter-associated uri-
nary tract infection in mice. Targeting metabolic pathways that are important in infec-
tion may lead to new treatments against multidrug-resistant enterococcal infections.
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Enterococci have emerged as leading causes of hospital-associated infections thatare often associated with biofilms, including endocarditis and catheter-associated
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urinary tract infections (CAUTI) (1). Both disease manifestations for endocarditis and
CAUTI are thought to be biofilm mediated, and enterococci now rank as the second
leading cause of CAUTI in U.S. hospitals (1). The ability of enterococci to cause such
infections is in part due to their ability to adapt and survive in a variety of host environ-
ments that are often nutrient poor (2). Critical nutrient substrates that permit microbial
proliferation and induce pathology at the site of infection remain to be defined for
many types of infection. While several studies have examined transcriptional profiles of
enterococci grown in urine, serum, and abscesses (3–5), little is known of preferred
nutrients and how E. faecalis acquires them in the host.
We previously showed that the alternative sigma factor s54 (RpoN) contributes to in
vitro biofilm formation in E. faecalis, as an rpoN deletion mutant was shown to have an
altered biofilm matrix composition when grown in rich medium (6). The rpoN mutant
was less efficient at autolysis (less extracellular DNA [eDNA] in the matrix), and the bio-
film became more labile than the parental strain to protease K treatment. In addition,
s54 (RpoN) is also known to regulate several phosphotransferase systems (PTS) in E.
faecalis, including a mannose/glucose permease, Mpt (7), making it a good candidate
for exploring its contribution to in vivo fitness.
In contrast to other sigma factors, s54 is unable to initiate open complex formation
upon association with target DNA and the core RNA polymerase and requires the assis-
tance of a bacterial enhancer binding protein (bEBP) (8). In E. faecalis, four bEBPs are
encoded on the V583 genome (MptR, MpoR, MphR, and LpoR), with a fifth (XpoR) dis-
rupted by an insertion element (7). The genes encoding each of these bEBPs are posi-
tioned immediately upstream of their respective sugar PTS genes (7). The best-charac-
terized PTS in E. faecalis is the aforementioned Mpt mannose/glucose permease (7, 9,
10), owing to the fact that components of this PTS complex are known cellular recep-
tors for class IIa and IIc bacteriocins (11).
Work by Opsata et al. (10) characterized the transcriptional profile of a mutant of
mptD, a component of the Mpt PTS complex, that conferred resistance to pediocin PA-
1, a known class IIa bacteriocin. These authors identified a number of differentially
expressed genes in the mptD mutant that contained putative catabolite-responsive
element (cre) sites based on similarity to consensus cre sites from Bacillus subtilis (12).
cre sites are pseudopalindromes and are considered a low-conservation consensus
sequence of WTGNNARCGNWWWCAW (strongly conserved residues are underlined)
(13). In low-GC-content Gram-positive bacteria, cre sites on DNA are bound by a pro-
tein complex consisting of the carbon catabolite repressor CcpA and the phosphoryl-
ated Ser-46 form of Hpr (Hpr-46-P) (14). CcpA is a global regulatory protein that plays a
critical role in regulating the expression of genes involved in secondary catabolite
uptake and utilization in Gram-positive bacteria (15).
Because s54 has been shown to regulate the expression of various genes involved in
metabolism and virulence in other bacteria (16–20), we performed a microarray transcrip-
tional analysis to identify genes whose expression was differentially expressed in the E.
faecalis V583 strain and an isogenic DrpoN mutant. Furthermore, we also tested the role
of RpoN and CcpA in biofilm formation under drip-flow conditions, as well as colonization
in vivo using a rabbit endocarditis infection model and a murine model of catheter-associ-
ated urinary tract infection to determine whether RpoN-dependent metabolic pathways
contribute to biofilm-associated infections. To our knowledge, this report represents the
first examination of the contribution of either s 54 (RpoN) or CcpA to in vivo fitness in E.
faecalis. Overall, this study provides important evidence linking basic metabolism with in
vivo growth and provides the rationale for several distinct pathways that could be tar-
geted as a potential therapeutic for treating enterococcal infections.
RESULTS
RpoN and MptR regulate glucose uptake and are essential for mannose
utilization.We previously demonstrated that deletion of rpoN has no growth defect in
rich media, including tryptic soy broth and Todd-Hewitt broth (THB) (6). Several sugar
uptake systems in E. faecalis are known to be regulated by RpoN (7). Therefore, it was
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of interest to determine whether RpoN contributed to fitness in a chemically defined
medium (CDM) (21, 22) supplemented with various sugars as the sole carbon source.
As RpoN also requires a bEBP for open complex formation in order for transcription to
proceed, we also evaluated the contribution of the four bEBPs in E. faecalis V583 by
constructing deletion mutants for lpoR, mphR, mpoR, and mptR. The fifth bEBP (XpoR)
identified in E. faecalis possesses a natural insertion of an IS256 element in the xpoR
gene in the E. faecalis V583 genome. Because of the location of the IS256 insertion
within xpoR, it was unclear whether XpoR function was disrupted by the IS256 element;
we therefore constructed a deletion mutant that removed the corresponding xpoABCD
PTS system and assessed its contribution directly. The deletion of mphR, mpoR, lpoR, or
xpoABCD did not impact growth when glucose or mannose was present as the sole car-
bon source (see Fig. S1 in the supplemental material). In contrast, the rpoN and mptR
deletion mutants displayed poor growth. Figure 1A shows that both the rpoN and
mptR mutants grew very poorly in CDM supplemented with 10mM glucose, and that
this phenotype is complementable, as the rpoN complement and the mptR genetic
revertant grew at a rate equivalent to that of the parental strain. Because deletion of
rpoN and mptR had such a drastic impact on glucose-dependent growth, it was of in-
terest to determine whether a homolog of the primary glucose transporter (PtsG) in
Bacillus subtilis contributed to glucose uptake in E. faecalis. We therefore constructed a
deletion mutant of ef1516 and assessed its growth in CDM supplemented with either
10mM or 100mM glucose (see Fig. S2 in the supplemental material). EF1516 shares
approximately 39% amino acid sequence identity and 56% sequence similarity with
PtsG in B. subtilis. We did not detect a role for EF1516 in growth with glucose as the
sole carbon source in E. faecalis, as there was no significant difference in growth
between the ef1516 mutant and the parental V583 strain (Fig. S2).
To confirm that the poor growth of mptR was related to the direct regulation of the
Mpt PTS system, we also constructed and evaluated an mptBACD mutant. The
mptBACD mutant phenocopied the growth of mptR, suggesting that the inability of
rpoN and mptR mutants to activate expression of the Mpt PTS system is responsible for
their poor growth in glucose-dependent conditions (Fig. S1). At 100mM glucose, the
rpoN and mptR mutants showed improved growth but never achieved the maximal
growth observed with the parental strain (optical density at 600 nm [OD600], ;0.4 ver-
sus ;0.6), suggesting alternative routes of glucose uptake at increasing concentrations
of glucose. In contrast, the growth defect of the mutants in CDM that included man-
nose as the principal carbon source was not rescued by increasing the concentration
of mannose (Fig. 1B), suggesting that the Mpt PTS controlled by s 54 and MptR repre-
sents the sole mannose transporter in the cell.
To ascertain the sugar specificity of the PTS controlled by MptR and s 54, we also
grew cells in CDM with N-acetylglucosamine (GlcNAc) and fructose as a carbon source.
As shown in Fig. 1C and D, the absence of either s54 or MptR does not alter growth
when N-acetylglucosamine or fructose is the main carbon source.
Transcriptional analysis of the E. faecalis V583 DrpoN strain. RpoN orthologs
impact global gene expression in a variety of bacteria, but the genes that they regulate
are functionally divergent (19, 23, 24). In E. faecalis, the only genes predicted to be
directly regulated by RpoN are putative PTS operons, each of which contains the dis-
tinct 224/212 promoter element (TTGGCACNNNNNTTGCT) thought to be responsive
to RpoN (7). Because of its role in glucose uptake, we hypothesized that RpoN likely
affects a larger regulatory gene network at the transcriptional level. Therefore, using
DNA microarrays of E. faecalis strain V583, the transcriptional profile of the V583 DrpoN
strain was compared to those of the parental strain V583 and an rpoN-complemented
strain.
Compared to the parental strain and the rpoN-complemented strain, mRNA abun-
dance in the rpoN mutant differed for transcripts corresponding to 340 genes (Fig. 2;
see also Table S4 in the supplemental material). Of the 340 differentially expressed
genes in the V583 DrpoN strain, transcripts for 255 genes were increased and those for
Transcriptomics of an E. faecalis rpoNMutant ®


























































85 genes were decreased ($3-fold) compared to those of the parental and comple-
mented strains. Of the differentially regulated genes, 23% are predicted to encode hy-
pothetical proteins with no known function, 18% encode transport and binding pro-
teins, 17% are energy metabolism related, and 13% encode PTS proteins. Of the six
PTS systems known to contain the 224/212 RpoN binding site in their promoter
FIG 1 Growth of Enterococcus faecalis in chemically defined medium (CDM) with the sugars indicated as the principal carbon
sources: (A) glucose, (B) mannose; (C) N-acetylglucosamine, and (D) fructose. The respective sugar concentrations are indicated above
each graph. Each graph is the average of three biological replicates, with three technical replicates each time (n= 9) and standard
error of the mean shown. The growth curves for each strain are shown in black (V583), blue (DrpoN), green (DmptR), gray (DrpoN::
rpoN), and gold (V583XmptR revertant).
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element (Mpt, Mpo, Mph, Lpo, Lpt, and Xpo), three were significantly downregulated
(mpt [ef0019-22], xpo [ef3210-13], and lpt [ef1017-19] by 152-fold, 6-fold, and 4-fold,
respectively), and no significant difference in expression was observed in the lpo, mpo,
and mph PTS systems.
Catabolite repression elements (cre) in differentially expressed genes in the
V583 DrpoN strain. The increased expression levels of genes encoding several sugar
uptake systems, as well as ABC transporters, in the transcription profile of the rpoN mu-
tant suggested a loss of catabolite control. In order to determine the basis of such reg-
ulation, we searched the regions upstream of the differentially expressed genes in the
rpoN mutant to identify cre sites. We used the cre consensus sequences suggested for
low-GC-content Gram-positive bacteria, 59-WTGNNARCGNWWWCAW-39 (13) and 59-
WTGWAARCGYWWWCW-39 (12), as our pattern queries and used the Regulatory
Sequence Analysis Tool (http://rsat.ulb.ac.be/), allowing for a 1-bp mismatch to identify
cre sites upstream of the genes that were upregulated in the rpoN mutant. Of the 255
genes that were upregulated in the rpoN mutant, cre sites were present in the pro-
moter regions of 46 genes; due to some loci comprising operons, this accounts for 109
genes, which represents 42.74% of the upregulated genes in the rpoN mutant (see
Table S5 in the supplemental material). It is of note that we identified a three-gene op-
eron (ef1017-19), which encodes the Lpt PTS complex that was downregulated in the
rpoN mutant that also contained a cre site, indicating that this operon may also be
regulated by CcpA for expression.
Identification of cell envelope-associated or secreted gene products among
the differentially expressed genes in the rpoN mutant that contain cre sites. To
identify cell envelope-associated or secreted gene products from the pool of differen-
tially expressed genes in the rpoN mutant that also contained cre sites, we analyzed
FIG 2 Pie chart depicting the functional distribution of the 340 differentially regulated genes in the
DrpoN mutant. The number in each functional category is the percentage of the total differentially
regulated genes. PTS, phosphotransferase system.
Transcriptomics of an E. faecalis rpoNMutant ®


























































the 112 differentially regulated gene products (109 upregulated and 3 downregulated
in an rpoN mutant) identified in Table S5 for the presence of a signal peptide sequence
and signal peptidase cleavage site (SignalP 5.0) followed by analysis for the presence
of transmembrane domains (TMHMM/TMpred) or LPXTG cell wall-anchoring motifs
using PHI-BLAST and the pattern query for the sortase cell wall-sorting signal (L-P-
[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]) (25) with the E. faecalis collagen adhesion protein,
Ace, as the template query (26). Identification of predicted lipoproteins was performed
using Pred-Lipo. As summarized in Table 1, 36 of the 112 gene products analyzed con-
tained a signal peptide sequence and/or predicted transmembrane helices (TMHs),
suggesting that these differentially expressed and cre site-containing genes encode
proteins that are cell envelope-associated or secreted. Among these 36 genes, 27
encode predicted transport proteins, five of which (ef1234, ef1397, ef2221, ef2234, and
ef2237) encode predicted lipoproteins involved in substrate binding associated with
ABC transporters. One notable PTS system potentially regulated by the presence of a











EF0104-08 EF0108 C4-dicarboxylate transporter; putative 13.04 2146 2132 ATGAAAGCGCATTCT 0.997 13
EF0114 Glycosyl hydrolase, family 20 48.20 235 221 GTGTATGCGCTTTCT 0.980 1
EF0292-91 EF0292 PTS system, IIC component 6.62 251 237 ATGTAAACGGATACA NA 10
EF0362-61 EF0361 Chitinase, family 2 69.31 241 227 CTGTAAGCGCATACA 1.000 0
EF0362 Chitin binding protein; putative 83.75 241 227 CTGTAAGCGCATACA 1.000 1
EF0439 Immunity protein PlnM; putative 13.54 249 235 ATGAAAACGTTATCA NA 2
EF0551-55 EF0552 PTS system, IIC component 6.21 285 270 ATACAAACGCTTTCAT NA 6
EF0553 PTS system, IID component 11.35 285 270 ATACAAACGCTTTCAT NA 5
EF0569 Potassium-transporting ATPase, subunit C 23.16 2169 2154 ATGCTAGTGGAATCAA 0.979 1
EF0635 Amino acid permease family protein 25.11 2270 2255 TTAGGAGCGTAAACAT 0.920 12
EF1017-19 EF1019 PTS system, IIB component 24.49 2173 2158 TTGGAAACGCACACAA NA 8
EF1207 Citrate carrier protein, CCS family 8.54 253 239 ATGTAAACGTTTTCT NA 12
EF1232-34 EF1232 ABC transporter, permease protein 8.63 281 267 ATGTAAGGGTTTACA NA 6
EF1233 ABC transporter, permease protein 13.83 281 267 ATGTAAGGGTTTACA 0.999 6
EF1234 ABC transporter, substrate binding protein; putative 12.52 281 267 ATGTAAGGGTTTACA 1.000 6
EF1392-1400 EF1397 Molybdenum ABC transporter, molybdenum binding
protein
23.85 238 224 GTGTAAACGTTAACA 0.999 1
EF1398 Molybdenum ABC transporter, permease protein 26.30 238 224 GTGTAAACGTTAACA NA 5
EF1400 Cadmium-translocating P-type ATPase 6.43 238 224 GTGTAAACGTTAACA NA 6
EF1663-1557 EF1657 PTS IIC membrane protein; putative 5.80 261 247 ATGTAAACGCATACA 0.765 8
EF1800 Hypothetical protein 4.01 261 247 ATGAAAGCGTGTTCA 1.000 2
EF1805-01 EF1802 PTS system, IID component 7.35 230 216 TTGAAAGCGTTTACT NA 5
EF1803 PTS system, IIC component 8.28 230 216 TTGAAAGCGTTTACT NA 7
EF1824 Glycosyl hydrolase, family 31 6.82 2255 2241 ATGAAAACGCATTCA 0.827 1
EF1929-27b EF1927 Glycerol uptake facilitator protein 36.40 2146 2132 TTGAAAGCGTTGTCT 0.724 6
236 222 TTGAAATCGTTTTCT
EF2223-21 EF2221 ABC transporter, substrate binding protein 128.09 238 224 ATGAAAACGCTATTA 1.000 1
EF2222 ABC transporter, permease protein 114.80 238 224 ATGAAAACGCTATTA 0.996 6
EF2223 ABC transporter, permease protein 257.25 238 224 ATGAAAACGCTATTA 0.986 6
EF2237-32 EF2232 ABC transporter, permease protein 4.20 235 221 ATTAAAGCGCTTTCT 0.997 6
EF2233 ABC transporter, permease protein 8.46 235 221 ATTAAAGCGCTTTCT 0.972 5
EF2234 Sugar ABC transporter, sugar binding protein; putative 17.24 235 221 ATTAAAGCGCTTTCT 1.000 1
EF2237 Lipoprotein 7.17 235 221 ATTAAAGCGCTTTCT 1.000 1
EF2863 Endo-beta-N-acetylglucosaminidase 62.34 245 231 TTGTAAGCGCTAACA 1.000 1
EF3023 Polysaccharide lyase, family 8 8.85 2209 2195 GTGAAAGCGTAAACA 1.000 2
EF3142-34b EF3138 PTS system, IID component 17.41 2374 2360 ATGAAAAGGCATTCA NA 5
268 234 ATGTAAACGATTACA
EF3139 PTS system, IIC component 7.55 2374 2360 ATGAAAAGGCATTCA NA 7
268 234 ATGTAAACGATTACA
EF3327 Citrate transporter 7.22 245 231 TTGTAAGCGTTAACA NA 12
aStrongly conserved residues of the cre consensus sequence are underlined.
bGenes/operons with more than one predicted cre site.
cNA, not applicable.
dTMH, transmembrane helix.
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predicted cre site near the translation start site was EF0551-55. This PTS system resides
within the known pathogenicity island present in V583 (27). In addition to transport
functions, a putative family 8 polysaccharide lyase (EF3023) and a family 31 glycosyl
hydrolase (EF1824) were the only gene products from this cohort that contain a pre-
dicted LPXTG cell wall-anchoring motif, suggesting that these proteins are anchored
on the bacterial cell surface and interact with the external environment. Last, three of
the 31 genes listed in Table 1 (ef0114, ef0361, and ef2863) encode glycosyl hydrolases
thought to be secreted into the external environment, as they contain predicted signal
peptides and signal peptidase cleavage sites. Encoded in the same operon as ef0361,
ef0362 encodes a chitin binding protein that is also predicted to be secreted into the
surrounding environment. Overall, this set of in silico analyses indicates that a relatively
small cohort of differentially expressed genes in the rpoN mutant that also contain pre-
dicted cre sites are likely to be involved in the interaction of the bacterial cell with its
environment.
Quantitative real-time PCR of differentially expressed genes in the rpoN
mutant that are CcpA dependent and independent. To validate the microarray data,
we performed quantitative real-time PCR (qRT-PCR) on a set of genes that represented
both upregulated (ef0891 and ef2223) and downregulated (ef0019 [mptB], ef1017 [lptB],
and ef3210 [xpoA]) genes in the rpoN mutant. This list of validated genes included
those whose expression profiles were found to be in common with the previous mptR
and mptD mutant transcriptomes (ef0019 and ef2223) (10), as well as those genes that
were found to be unique to the rpoN mutant (ef1017, ef3210, and ef0891). We exam-
ined the expression of ef0891 and ef2223 in the rpoN mutant by using qRT-PCR to com-
pare transcript abundance to that in the parental and rpoN-complemented strains. The
results shown in Fig. 3A and B validate the array data, as relative expression for ef0891
and ef2223 was significantly increased in the rpoN mutant. The expression of ef2223-21,
an operon encoding an ABC transporter, was the most abundantly upregulated tran-
script in the rpoN mutant that also contained a cre site within the promoter region
(Tables S4 and S5). To confirm whether the expression of ef2223 is also CcpA depend-
ent, qRT-PCR was performed on RNA isolated from the wild-type, ccpA mutant, and
ccpA-complemented strains. Figure 3B shows that the expression of ef2223 is highly
upregulated in the ccpA mutant background relative to the parental V583 strain and
ccpA complement. In contrast, ef0891 expression appears to be independent of CcpA,
as there was no significant difference in ef0891 expression in the ccpA mutant back-
ground relative to the parental V583 and complemented strains (Fig. 3A). This result
FIG 3 Quantitative real-time PCR (qRT-PCR) analysis of selected CcpA-dependent and independent
regulated genes that were highly upregulated in DrpoN. RNA was isolated from mid-log-phase
cultures of V583, DrpoN, DrpoN::rpoN, DccpA, and DccpA::ccpA strains grown in chemically defined
medium supplemented with 100mM glucose; RNA was subsequently converted to cDNA. The cDNA
was subjected to qPCR analysis and quantified using the threshold cycle (DDCT) method with the
threshold cycle values for the gene of interest, namely ef0891 (A) and ef2223 (B, normalized to the
endogenous control (ef0005 [gyrB]). Results represent the averages of three independent biological
experiments. Error bars indicate the standard deviation of the mean. Statistical analysis was done by
one-way analysis of variance (ANOVA), with significance values set to P, 0.0001 (***).
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indicates that the expression of ef2223 is likely indirectly upregulated as a consequence
of rpoN deletion and is directly regulated by CcpA due to the presence of a predicted
cre site near its promoter region. In contrast, the differential expression of ef0891 is
unique to the rpoN mutant, as no change was observed in a ccpAmutant.
To confirm expression of genes that were downregulated in the rpoN mutant, we
focused on three PTS operons predicted to contain the consensus 224/212 RpoN-de-
pendent promoter (ef0019, ef1017, and ef3210). The results shown in Fig. 4A to C con-
firmed that these three genes were significantly downregulated in the rpoNmutant rel-
ative to the parental V583 and rpoN-complemented strains.
The most downregulated genes in the rpoN mutant array were the mptBACD op-
eron encoding the Mpt PTS system; this was confirmed in the qRT-PCR data using
mptB (ef0019), expression of which was reduced ;930-fold in the rpoN mutant com-
pared to that in the parental strain. In addition to mpt genes, we also confirmed
reduced expression of the lptBAC operon using lptB (ef1017), which was reduced
;100-fold in the rpoN mutant, and the xpoABCD operon using xpoA (ef3210), which
was reduced ;20-fold (Fig. 4). These observations are consistent with RpoN playing a
direct role in the regulation of these PTS systems, as the promoters for each of these
PTS systems contains a predicted 224/212 consensus RpoN-dependent promoter. As
the lptBAC operon is unique among RpoN-dependent genes in that it is not immedi-
ately proceeded by a gene encoding a bEBP, we hypothesized that LpoR (ef1010) is
likely involved in regulating the expression of the lptBAC (ef1017-19) PTS operon, as it
is encoded in close proximity. We observed by qRT-PCR that the deletion of lpoR
resulted in an ;100-fold decrease in expression of lptB (ef1017) in CDM supplemented
with 100mM glucose relative to that in the parental and lpoR genetic revertant strains
(Fig. 4C). This suggests that the LpoR bEBP is involved in activating the expression of
the lpt PTS operon.
Of the differentially expressed genes that were downregulated in the rpoN mutant,
only the lptBAC promoter region possessed a putative cre site (Table S5). To confirm
whether the regulation of the lpt PTS operon is also dependent on CcpA, qRT-PCR was
performed on RNA isolated from wild-type, ccpA mutant, and ccpA-complemented
strains grown to the mid-exponential phase in CDM supplemented with 100mM glu-
cose. Figure 5A shows that the expression of lptB (ef1017) is upregulated 10-fold in the
ccpAmutant background relative to that in the parental V583 and ccpA-complemented
FIG 4 qRT-PCR analysis of RpoN-dependent expression of (A) ef0019 (mptB) and (B) ef3210 (xpoA). RNA was isolated from cultures
of V583, DrpoN, and DrpoN::rpoN strains grown in CDM supplemented with 100mM glucose and was subsequently converted to
cDNA. (C) qRT-PCR analysis of RpoN- and LpoR-dependent expression of ef1017 (lptB). RNA was isolated from cultures of V583,
DrpoN, DrpoN::rpoN, DlpoR, and V583XlpoR revertant strains grown in CDM supplemented with 100mM glucose and was
subsequently converted to cDNA. The cDNA was subjected to qPCR analysis and quantified using the DDCT method with the
threshold cycle values for ef0019, ef1017, and ef3210 normalized to the endogenous control (ef0005 [gyrB]). Results represent
averages of three independent biological experiments. Error bars indicate the standard deviation of the mean. Statistical analysis
was done by one-way ANOVA, with significant values set to P, 0.0001 (***).
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strains. In contrast, mptB (ef0019) and xpoA (ef3210) expression appears to be inde-
pendent of CcpA, as there was no significant difference in expression in the ccpA mu-
tant background relative to that in the parental V583 and complemented strains
(Fig. 5B and C).
The EF2223-21 ABC transporter contributes to glucose importation. In the pres-
ence of high glucose concentrations (100mM), the growth defect in both the mptR
and rpoN mutants appeared to be partially rescued, suggesting that at higher concen-
trations, glucose is being transported via other uptake system(s). The upregulation of
several PTS systems and transport proteins in the rpoN mutant gives credence to this
hypothesis. Of note is gene ef2223, which encodes an ABC transporter permease pro-
tein, a member of the ef2223-21 ABC transporter operon that was found to be 257.25-
fold upregulated in the rpoN mutant, possesses a cre site, and was also confirmed to
be highly upregulated in the ccpA mutant (Table S4 and Fig. 3). We hypothesized that
when the Mpt PTS system is incapable of importing glucose efficiently into the cell as a
consequence of the rpoN deletion, CcpA will derepress to allow expression of ef2223-
21 in order to bring glucose into the cell as a non-PTS glucose importer. To test this hy-
pothesis, ef2223-21 deletion mutants, singly and in combination with the DrpoN mu-
tant, were grown in CDM supplemented with 10mM or 100mM glucose. Figure 6 illus-
trates that a single deletion of ef2223-21 does not impede the overall growth relative
to that of the wild type in CDM supplemented with either concentration of glucose.
However, a double deletion mutant of rpoN and ef2223-21 results in a significant
attenuation in growth relative to that of V583 DrpoN alone; this reduction in growth is
most pronounced in CDM supplemented with 10mM glucose. At the higher concen-
tration of glucose (100mM), the difference in growth of the double mutant (DrpoN
Def2223–ef2221) relative to that of the rpoN mutant is less pronounced, suggesting
that additional low-affinity glucose transporters likely contribute to glucose
importation.
Role of RpoN and CcpA in enterococcal biofilm formation. We have previously
shown that the E. faecalis V583 DrpoN strain exhibited resistance to autolysis and
formed altered biofilm structures in which the matrix was more protease K labile (6).
The biofilm conditions in the prior study were based on a static biofilm under nutrient-
rich conditions, and we were interested in knowing how RpoN and CcpA might con-
tribute to biofilm formation under flow conditions under nutrient-poor conditions to
more closely mimic the environment that is likely encountered at sites of infection. To
assess the role of RpoN and CcpA in regulating biofilm formation, we quantified the
FIG 5 qRT-PCR analysis of selected CcpA-dependent and independent regulated genes that are RpoN dependent. RNA was
isolated from mid-log cultures of V583, DccpA, and DccpA::ccpA strains grown in CDM supplemented with 100mM glucose and
was subsequently converted to cDNA. The cDNA was subjected to qPCR analysis and quantified using the DDCT method with the
threshold cycle values for the gene of interest, namely ef1017 (A), ef0019 (B), and ef3210 (C), normalized to the endogenous
control (ef0005 [gyrB]). Results represent the averages of three independent biological experiments. Error bars indicate the
standard deviation of the mean. Statistical analysis was done by one-way ANOVA, with significance values set to P, 0.0001 (***).
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level of biofilm formation under flow conditions of rpoN and ccpA mutant strains using
a drip-flow bioreactor (DFBR) (28, 29) in 0.1 MM9YEGC medium (modified M9 me-
dium supplemented with yeast extract, glucose, and casamino acids). In the absence of
rpoN, there is a significant 6-fold decrease in biofilm formation relative to that of the
parental V583 strain and rpoN complement, whereas in the absence of ccpA, there is a
more drastic decrease in biofilm formation that is represented by an approximate 170-
fold decrease in biofilm formation compared to that of parental V583 or the ccpA-com-
plemented strain (Fig. 7A and C). This suggests that factors regulated by RpoN and
CcpA play a role in enterococcal biofilm formation. The rpoN mutant did exhibit a
slight planktonic growth defect in the biofilm growth medium (MM9YEGC) (Fig. 7D),
whereas there was no significant difference in growth relative to that of V583 in rich
laboratory medium (Todd-Hewitt broth) (Fig. 7F). In contrast to the rpoN mutant, the
ccpA mutant did not exhibit significant differences in planktonic growth relative to
that of the parental V583 strain in biofilm growth medium (MM9YEGC) or in rich labo-
ratory medium (Todd-Hewitt broth) (Fig. 7D and F), indicating that the biofilm growth
defect observed in the ccpA mutant is unique to the biofilm microenvironment. To as-
certain whether the biofilm phenotype associated with the rpoN mutant was linked to
the inability to import the available carbon source in the biofilm medium, the rpoNmu-
tant was assessed under drip-flow biofilm conditions with the biofilm growth medium
containing fructose instead of glucose. Under these biofilm growth conditions, there
was no significant difference between the rpoN mutant and the wild-type and the
rpoN-complemented strains (Fig. 7B).
Role of RpoN and CcpA in enterococcal virulence. On the basis of the biofilm
results and the observation that RpoN plays a key role in regulating the uptake of man-
nose and glucose, we hypothesized an important contribution of RpoN to the in vivo
fitness of E. faecalis. To determine the role of enterococcal RpoN in virulence we used
two models of infection, rabbit endocarditis (30) and a murine model of catheter-asso-
ciated urinary tract infection (31). In the rabbit endocarditis model, the parental strain
(V583) was compared to its isogenic rpoN mutant for the ability to establish infective
endocarditis, and mean bacterial burden on the heart valve vegetation, heart, liver,
spleen, and kidneys, as well as in the blood, were assessed. As observed in Fig. 8, a sig-
nificant reduction (P , 0.05) of approximately 10-fold in the mean bacterial burden in
comparison to that of the parental strain was noted in the blood and in all examined
organs of the rabbits infected with DrpoN, suggesting that rpoN contributes to infec-
tive endocarditis in rabbits. We also assessed the contributions of both RpoN and CcpA
in the murine model of CAUTI. Similarly to the observation in the endocarditis model,
the rpoN mutant was significantly attenuated in CAUTI, as shown by the reduced
FIG 6 Growth of E. faecalis in chemically defined medium with glucose as the sole carbon source. The respective glucose
concentrations are indicated below each panel. Each graph is the average of three biological replicates, with three
technical replicates each time (n= 9) and standard error of the mean shown. The growth curves for each strain are shown
in black (V583), blue (DrpoN), red (Def2223–ef2221), and pink (DrpoN Def2223–ef2221).
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numbers of bacteria (P, 0.05) recovered from the bladder (6.7-fold lower) and cathe-
ter (32.6-fold lower) of the DrpoN strain-infected mice compared to those infected with
the wild-type strain V583 (Fig. 9). In comparison to the wild-type, the ccpA mutant was
more highly attenuated for in vivo fitness, as the mean bacterial numbers for the ccpA
mutant isolated from the catheter and bladder were 500-fold and 90-fold lower,
respectively, than those of the wild type (P, 0.005).
DISCUSSION
The sigma factor s 54 (RpoN) has historically been linked to the regulation of nitro-
gen metabolism, even before the protein was recognized as a sigma factor (32).
FIG 7 Quantification of biofilm formation of V583, DrpoN, and DrpoN::rpoN strains using a drip-flow biofilm reactor (DFBR) in (A) MM9YEGC and (B)
MM9YEFC media. (C) Quantification of biofilm formation of V583, DccpA, and DccpA::ccpA strains using a drip-flow biofilm reactor (DFBR) in MM9YEGC
medium. Results represent the averages of three independent biological experiments with error bars indicating the standard deviation of the mean.
Statistical analysis was done by one-way ANOVA, with significance values set to P, 0.05 (*). (D to F) Growth of E. faecalis in (D) MM9YEGC, (E) MM9YEFC,
and (F) THB media. Each graph is the average of three biological replicates, with three technical replicates each time (n= 9) and standard error of the mean
shown. The growth curves for each strain are shown in black (V583), blue (DrpoN), dark blue (DrpoN::rpoN), purple (DccpA), and dark purple (DccpA::ccpA).
FIG 8 Enterococcal burden in rabbits infected with E. faecalis strains. Rabbits were euthanized
postinfection, and organs were harvested to enumerate bacterial burden. Bacterial burden for wild-
type V583 (l) and DrpoN (~) are expressed as log10 CFU/g of harvested tissue. The horizontal line
represents the median value for each group. A Mann-Whitney test was used to determine
significance, which is indicated as follows: **, significant P value , 0.05 relative to V583; *, significant
P value , 0.1 relative to V583.
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However, it is now well established that RpoN regulates a plethora of cellular proc-
esses, including flagellar biosynthesis in Escherichia coli (23), cold shock adaptation in
Bacillus subtilis (33), sporulation and toxin production in Bacillus cereus (34), biofilm for-
mation in E. faecalis (6), and PTS-mediated regulation in Gram-negative and Gram-posi-
tive organisms (24, 35, 36). Others have conducted several comparative studies for
understanding s54 and bEBP-mediated regulation with the intent of identifying a uni-
fying biological theme for the wide range of RpoN-dependent processes (37–39).
Francke et al. performed an extensive comparative genomic analyses and proposed
that s 54 is a central player in the control of cellular processes that involve the physical
interaction of an organism with its environment (host colonization, biofilm, etc.) by
directly regulating the expression of genes involved in the transport and biosynthesis
of the main precursors of the bacterial exterior (40).
s54 binding sites (TTGGCACNNNNNTTGCT) have previously been identified upstream
of genes predicted to encode sugar PTS systems (Mpt, Mpo, Lpo, Lpt, Mph, and Xpo) in E.
faecalis, and each PTS system is thought to be regulated by a bEBP that is predicted to
interact with RpoN to allow open complex formation (7). Of the six predicted RpoN-
dependent PTS systems, three (mpt, lpt, and xpo) were found to be differentially
expressed under CDM plus glucose growth conditions, but only the Mpt system
plays a significant role in glucose- and mannose-dependent growth, as the mptR
mutant and the mptBACD mutant phenocopy the rpoN mutant for growth in CDM
supplemented with glucose or mannose. We have also previously shown that an
DrpoN mutant is resistant to 2-deoxyglucose (2DG; a toxic homologue of glucose)
(6), and mutants resistant to 2DG have been shown to localize mutations within
mptR or the mptBACD operon (7, 41) thus strengthening the notion that Mpt is the
major glucose uptake system in E. faecalis.
In contrast, neither the other known bEBPs (MphR, MpoR, and LpoR) nor the
XpoABCD PTS system contribute to glucose-dependent growth. We also show here for
the first time that the lptBAC PTS operon expression is dependent on the LpoR bEBP.
Why the Lpt and Xpo PTS systems are induced with glucose as a principal carbon
source is unclear, as neither appears to contribute to glucose-dependent growth in a
chemically defined medium. Previously, it was hypothesized that the Xpo PTS complex
was inactive in E. faecalis V583 due to a truncated XpoR that lacks its C-terminal regula-
tory domain due to an IS256 insertion in the xpoR gene (7). However, our results indi-
cate that the expression of the xpo PTS system is dependent on RpoN, suggesting that
the truncated XpoR may still be functional. Others have shown that a bEBP that only
possesses its AAA1 ATPase domain is capable of stimulating transcription of RpoN-de-
pendent promoters in Salmonella enterica subsp. enterica serovar Typhimurium LT2
FIG 9 RpoN and CcpA contribute to enterococcal virulence in the murine model of CAUTI. Female
C57BL/6 mice were euthanized after 48 h postinfection. Bacterial burden is expressed in a logarithmic
scale for wild-type V583, DrpoN, and DccpA strains in (A) implanted catheters retrieved from the mice
and (B) homogenized bladders. The horizontal bar represents the median of each group of mice.
Statistical significance as determined by Mann-Whitney test is represented as follows: **, significant P
value , 0.05 relative to V583; ***, significant P value , 0.005 relative to V583.
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(42), suggesting that, in some instances, bEBPs may activate transcription of its RpoN-
dependent genes without possessing regulatory and/or DNA binding domains.
Another possibility is that one of the other five bEBPs encoded in the E. faecalis V583
genome may be used to activate the RpoN-dependent xpo operon. Deciphering the
sugar specificity of the Xpo system remains an active area of investigation.
One of the common themes observed with the transcriptional profile of the rpoN
mutant was the significant upregulation of genes with predicted cre sites, suggestive
of an involvement with the major catabolite control protein CcpA. Among the cohort
of cre-regulated genes, the only cre-containing genes that were significantly downre-
gulated in the rpoNmicroarray were those of the lpt PTS operon. Our observations con-
firm a role for CcpA in the regulation of the lpt PTS. In general, cre sites present in the
promoter regions of genes repressed by CcpA overlap the –10 promoter element or
can be found immediately downstream of the –10 box (43). Based on our cre site
query, we identified a cre site located 158 bp upstream of the start codon of ef1017
(lptB) and positioned 92 bp upstream of the predicted –24/–12 promoter. RpoN-medi-
ated transcriptional activation requires the binding of bEBP to an upstream activation
sequence (UAS) to facilitate open complex formation. The UAS is generally positioned
80 to 150 bp upstream of the –24/–12 promoter, and bEBP binding to the UAS requires
DNA looping to bring the bEBP into close contact with the RNA polymerase (44). The
location of the cre site positioned 92 bp upstream of the lpt operon –24/–12 promoter
suggests that CcpA may actively compete with LpoR for binding to an as-yet-unidenti-
fied UAS. To our knowledge, this would be the first instance in which CcpA exhibits
repressor activity by competing with a bEBP rather than with RNA polymerase to pre-
vent transcription of target genes. Understanding the specifics of this observation, as
well as the sugar specificity of the Lpt PTS complex remains a component of ongoing
studies.
Based on the in silico analysis conducted in this study, among the cohort of cre-
regulated genes, nearly a third (32.1%) are predicted to be cell envelope-associated or
secreted gene products. The majority of the genes listed in Table 1 encode transport
and transport binding proteins, including a novel PTS system (EF0551-55) that resides
within a known pathogenicity island in strain V583 (27), potentially linking sugar metabo-
lism with pathogenesis or increased competitive fitness in a complex intestinal ecology.
The remaining cre site-regulated genes encode either cell wall-anchored proteins or
secreted glycosyl hydrolases (exo- or endoglycosidases). Endoglycosidases are enzymes
that function to release oligosaccharides from glycoproteins or glycolipids and do not
require the presence of a terminal sugar residue to affect cleavage, thus distinguishing
them from known exoglycosidases. The endoglycosidases also serve to release avail-
able nutrients from the host and can therefore be thought of as nutrient acquisition
systems. The genes for each of the endoglycosidases (ef0114 [EndoE]; ef0362-ef0361
[chiBA], and ef2863) were $50-fold upregulated in the rpoN deletion mutant com-
pared to V583 (see Tables S4 and S5 in the supplemental material). These genes have
also been shown to be upregulated in various transcriptomic studies conducted in
human urine, serum, and an in vivo subdermal abscess model (3–5), indicating bio-
logical host colonization relevance in an environment that is glucose limited. The
contribution of these glycosyl hydrolases to E. faecalis virulence is a component of
ongoing studies. With respect to the cohort of genes described in Table 1, we pro-
pose that the differentially expressed genes in the rpoN mutant that are putatively
regulated by CcpA are involved in the physical interaction with its glucose-limited
host environment, further supporting the findings in Francke et al. (40) that RpoN is
involved in the central control of the bacterial exterior.
Leboeuf et al. showed that a ccpA insertion mutant in strain JH2-2 had a signifi-
cantly altered growth rate in semisynthetic medium (Folic AOAC medium; Bacto) plus
0.15% glucose. A ccpA deletion mutant displayed a slightly altered growth in CDM with
10mM glucose (see Fig. S3 in the supplemental material), but, in contrast, growth was
not significantly altered in either THB or MM9YEGC. These combined observations
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suggest that growth alterations caused by ccpA gene disruption are likely to be de-
pendent on growth medium as well as on strain. As previously stated, CcpA is known
to play a critical role in secondary carbon metabolism by repressing secondary catabo-
lite genes when preferred carbon sources are readily available, but CcpA also partici-
pates in the positive regulation of gene products known to be involved in central gly-
colytic pathways and overflow metabolism (45). Although secondary nutrient
acquisition systems would be predicted to be overexpressed in a ccpA mutant, in our
study this mutant performs poorly in vivo, as well as when grown under biofilm condi-
tions in vitro. The dysregulation of normal central metabolism that would occur in a
ccpA mutant likely explains its attenuated biofilm and in vivo phenotypes and is con-
sistent with a growing body of evidence for the role of CcpA in Gram-positive bacterial
pathogenesis (46–48). Of note, one of the E. faecalis lactate dehydrogenase genes,
ef0255 (ldh-1), contains a putative cre site. The location of the putative cre site within
the promoter region of ldh-1 predicts that CcpA acts as an activator of ldh-1 expression.
Leboeuf et al. (49) demonstrated by Northern blotting that ldh-1 expression was mar-
ginally reduced (2-fold) in a ccpA insertion mutant, suggesting that CcpA partially con-
tributes to the positive regulation of ldh-1 expression. While we did not observe differ-
ential regulation of ldh-1 expression in the rpoN mutant, Opsata et al. (10) observed a
slight drop (2.4-fold) in expression of ldh-1 in an mptD insertion mutant. Experimental
differences in terms of strain background, medium composition, and growth phase
between our study in comparison to other studies (10, 49) likely explain why we were
unable to observe a decrease in ldh-1 expression in our rpoN transcriptomic data.
Ldh-1 has been linked to promoting extracellular electron transfer (EET) for biofilm
matrix-associated iron-augmented energy production, thus leading to enhanced bio-
film growth in E. faecalis (50). With this link between lactate dehydrogenase and bio-
film formation, we hypothesize that when glucose is available, CcpA positively regu-
lates the expression of ldh-1, thus leading to enhanced biofilm growth. In support of
this hypothesis, increased glucose concentrations in biofilm culture medium have
been shown to enhance biofilm formation in E. faecalis (51, 52), suggesting that replete
glucose conditions during biofilm formation maintains CcpA-regulated ldh expression,
thus leading to enhanced biofilm growth. We observed by qRT-PCR that a ccpA dele-
tion mutant showed reduced ldh-1 expression in CDM supplemented with 15mM glu-
cose (see Fig. S4 in the supplemental material). The inability to fully activate ldh-1
expression in the ccpA mutant could partially explain the attenuated biofilm formation
phenotypes we observed. Additionally, recent work by Kaval et al. (53) showed that
CcpA regulates bacterial microcompartment (BMC) formation required for the utiliza-
tion of ethanolamine in E. faecalis by binding to a cre site in the eutS promoter. The ab-
sence of CcpA predictably increases the expression of eut genes and BMC formation.
The dysregulation of eut gene expression observed in a ccpA mutant likely results in
increased BMC formation and a predictable decrease in cell growth, likely due to the
metabolic demand placed on a cell to produce additional BMCs or the potential toxic-
ity associated with ethanolamine utilization (54). This defect would be expected to be
most pronounced in environments where ethanolamine utilization would occur, partic-
ularly in the gastrointestinal (GI) tract or possibly in other host anatomic sites, likely
contributing to the in vivo defect of a ccpA mutant. Our in vitro growth conditions
lacked supplemental ethanolamine, and we therefore did not observe a significant
change in gene expression for eut genes. Collectively, the observations with the rpoN
and ccpA mutants both in vitro and in vivo suggest that regulated metabolism is key to
successful colonization and infection. Too little nutrient acquisition of essential host
sugars (glucose and/or mannose) in the case of the rpoN mutant and dysregulated me-
tabolism observed in the ccpA mutant result in poor fitness compared to that of the
parental strain.
In vivo, the organism will face more hostile growth conditions, as preferable nutri-
ent sources are kept at growth-limiting conditions (i.e., glucose is present in normal
human serum at 4 to 8mM [55] and similar blood glucose levels are also observed in
Keffeler et al. ®


























































rabbits [56]). Importantly, secondary carbon sources in a host environment could be
host glycoproteins, such as high-mannose-type glycoproteins, which have been shown
to serve as a potential nutrient source for E. faecalis in vitro (57). Thus, beyond glucose,
an rpoN mutant’s failure to grow on mannose likely also contributes to its attenuated
phenotype in vivo.
It was noteworthy that the most abundantly upregulated transcript in the rpoN mu-
tant was a predicted sugar ABC transporter (EF2223-21). Deletion of this operon in
V583 did not display a significant change in growth; however, deletion of ef2223-21 in
the rpoN mutant background resulted in further attenuation of growth in CDM with
10mM glucose compared to the that of the rpoN mutant alone. Increasing the glucose
concentration to 100mM rescued this growth defect, suggesting that additional glu-
cose transporters are present in E. faecalis. In both Staphylococcus aureus (58) and
Streptococcus pyogenes (59), GlcU has been shown to contribute to glucose uptake
under low affinity conditions, and a GlcU homolog is also present in the V583 genome
(ef0928). Recent work by Kumar et al. (60) showed that GlcU expression compensates
for PTS-dependent glucose transport when E. faecalis is exposed to the lantibiotic nisin.
Their findings indicated that glucose was shuttled through the pentose phosphate
shunt pathway under GlcU-dependent conditions, as opposed to the conventional gly-
colytic pathway. GlcU was first characterized in Bacillus subtilis by Paulsen et al. as a
glucose:H1 symporter, which is dependent on the proton motive force for activity (61).
It will be of interest to examine whether GlcU in E. faecalis is responsible for the
improved growth of the rpoN and ef2223-21 mutant under elevated glucose condi-
tions. Although the nearest PtsG homolog in E. faecalis (EF1516) is not the primary glu-
cose transporter when the RpoN-dependent Mpt PTS system is functional, we cannot
rule out a glucose uptake contribution in the absence of the Mpt system. Intriguingly,
the deletion of rpoN resulted in a 14-fold increase in ef1516 expression, suggesting
that it may play a role in glucose uptake, but this will require additional investigation.
The gene encoding EF1516 does not appear to possess a cre site, so understanding
how the absence of rpoN influences the expression of ef1516 remains to be elucidated
in subsequent studies.
We present here a model for how RpoN and CcpA interface in the cell to regulate
central carbon metabolism (Fig. 10). In the absence of RpoN, there would be an altera-
tion in the relative abundance of the glycolytic intermediates glucose-6-phosphate
and fructose-1,6-bisphosphate within the cell, indicating insufficient carbon flow,
which would trigger the phosphatase activity of the bifunctional enzyme HprK/P that
dephosphorylates the PTS intermediate Hpr(Ser-P) (Fig. 10). A dephosphorylated Hpr
no longer binds to the catabolite control protein A (CcpA), and the dissociation of the
Hpr(Ser-P)-CcpA complex would alleviate the repression of transcription of cre-depend-
ent genes (20). In the DrpoN mutant, the inability to efficiently import glucose or man-
nose into the cell via the Mpt PTS complex influences the rate of carbon catabolite der-
epression. The expression seen in the array data with respect to cre site containing
genes is consistent with this interpretation.
MptR belongs to the LevR-like family of regulators, whose bEBP activation is trig-
gered by signal sensing through phosphotransferase regulation domains (PRDs) (8,
62). The activity of LevR-like regulators is controlled via phosphorylation of the bEBP
regulatory domain by the PTS enzymes, which the bEBP regulates in turn. The regula-
tory domains of LevR-like bEBPs contain two unique PRDs; one domain undergoes
HPr-mediated phosphorylation that leads to the activation of the bEBPs (PRD1), while
PRD2 undergoes EII-mediated phosphorylation that is inhibitory (8, 62). It is of note
that it has been described that when the substrate is present, EIIB preferentially phos-
phorylates the sugar, not the bEBP, to complete the PTS cascade (8, 62, 63). In the
model depicted in fig. 10A, we also propose that when glucose is readily available, HPr
becomes phosphorylated by EI via the phosphotransfer from the phosphoenolpyru-
vate (PEP) donor. HPr will transfer its phosphoryl group to the EII complex of the PTS
system in addition to MptR PRD1. Phosphorylated MptR (MptR-PRD1) can then elicit
Transcriptomics of an E. faecalis rpoNMutant ®


























































open complex formation of RpoN to turn on expression of the mpt PTS complex. In
contrast, when glucose is not readily available, MptR is phosphorylated by EIIB (MptR-
PRD2), which inhibits MptR activation, thus inhibiting the expression of the mpt PTS
genes (Fig. 10B).
In E. faecalis, the transcription profile of the rpoN mutant clearly shows that this
sigma factor contributes to the activation of several PTS systems, as well as its impact
FIG 10 Model for s54-mediated carbon catabolite repression (CCR). (A) Regulation of CCR-dependent genes in
wild-type E. faecalis V583. (B) Alleviation of CCR in an rpoN or mptR mutant. CcpA, catabolite control protein A;
Mpt, mannose PTS; cre, catabolite-responsive element; Hpr, histidine-containing phosphocarrier protein; EI,
enzyme I; HprK/P, bifunctional ATP-dependent Hpr kinase/phosphatase; PRD, phosphotransferase regulation
domain.
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on controlling the activity state of the Hpr (Ser-46) CcpA repressor. Approximately 10%
of the genome is differentially expressed by disruption of RpoN function, and under-
standing these complex metabolic circuits that also likely feed into the virulence
potential of E. faecalis will be the focus of ongoing studies.
MATERIALS ANDMETHODS
Bacterial strains and growth conditions. Bacterial strains used in this study are listed in Table S1 in
the supplemental material. For propagation of plasmids, Escherichia coli ElectroTen-Blue from
Stratagene was cultivated in Luria-Bertani (LB) broth supplemented with appropriate antibiotics when-
ever necessary. Unless otherwise mentioned, E. faecalis was cultured in Todd-Hewitt broth (THB; BD
Biosciences) containing appropriate antibiotics. For antibiotic selection, chloramphenicol (Cm) at a con-
centration of 10mg/ml and 15mg/ml was used for E. coli and E. faecalis, respectively.
Construction of in-frame markerless deletion. Using the temperature-sensitive cloning vector
pLT06 (64), isogenic in-frame deletion mutants of the genes encoding the four bEBPs were generated in
E. faecalis V583. Upstream and downstream flaking regions of the targeted activators were amplified
using primers listed in Table S2 in the supplemental material. The primer pairs MptRP1/MptRP2 and
MptRP3/MptRP4 were used to amplify flanking regions upstream and downstream of mptR, respectively.
To facilitate cloning, primers MptRP1/MptRP2 were designed with EcoRI/BamHI restriction sites, respec-
tively, whereas MptRP3/MptRP4 were designed with BamHI/PstI sites, respectively. For the construction
of the insert, the amplified regions were digested with BamHI, ligated, and reamplified with MptRP1 and
MptRP4. To generate pMG07 (mptR deletion vector), the amplified insert fragment was digested and
ligated with EcoRI/PstI cut pLT06 cloning vector. The ligated vector and insert were electroporated into
E. coli ElectroTen-Blue, and correct constructs were identified by colony PCR. The construct was screened
by restriction digest analysis and then electroporated into competent E. faecalis V583 cells. The MG07
(V583DmptR) strain was subsequently generated as previously described (64) and confirmed by PCR
using the primers MptR-Up and MptR-Down, and the paired genetic revertant from this screen was des-
ignated the MG07R (V583XmptR) strain. A similar approach was used to create all the remaining mutants
and/or revertants used in this study (Table S1).
Construction of in-frame markerless ccpA-complemented strain. Using the temperature-sensitive
cloning vector pLT06 (64), an isogeneic in-frame ccpA-complemented strain was generated in E. faecalis
V583. The entirety of the ccpA gene, including its upstream and downstream flanking DNA regions, was
amplified using the primer pair CcpAP1/CcpAP4 (Table S2). For cloning purposes, CcpAP1 and CcpAP4
were designed with EcoRI and PstI restriction sites, respectively. The amplified region was digested with
EcoRI and PstI, ligated into the EcoRI/PstI-digested pLT06 cloning vector, and then electroporated into E.
coli ElectroTen-Blue cells. The presence of the correct clone containing the recombinant plasmid was
identified by colony PCR. The plasmid construct was confirmed by restriction digest analysis and
sequenced. This plasmid was designated pEK26 and was subsequently electroporated into E. faecalis
V583DccpA cells. The insertion and excision of pEK26 to generate the V583 DccpA::ccpA (EK26) strain was
performed as previously described (64) and confirmed by colony PCR using the primers CcpAUp and
CcpADown.
Growth assessment under nutrient-limiting conditions. Using a single colony of each strain, liquid
cultures were started in THB and grown at 37°C overnight. For growth analysis, overnight cultures were
diluted 1:100 in complete defined medium (CDM) (21, 22) supplemented with a range of either glucose,
mannose, fructose, or N-acetylglucosamine concentrations (10mM and 100mM). Growth was monitored
for 12 h in an Infinite M200 Pro plate reader (Tecan Trading AG, Switzerland) at 37°C with orbital shaking
at 250 rpm. The experiment was biologically repeated three times, which included three technical repli-
cates each time. A similar approach was used to assess the growth of rpoN and ccpA mutant strains in
drip-flow biofilm growth medium (MM9YEGC or MM9YEFC) relative to that of V583.
Microarray analysis. Colony biofilms (65) were grown similarly to those reported previously (66).
Briefly, E. faecalis strains were grown overnight in 2ml of CDM cultures with 100mM glucose and 20mM
hematin added, shaking at 150 rpm at 37°C. Overnight cultures were subcultured 1:1,000 under the
same growth conditions and allowed to grow to an optical density (OD) of approximately 0.2, then
diluted in fresh medium to an A600 of 0.1 (approximately 10
8 cells/ml). A 10-ml aliquot of this solution
was added in three discrete spots to a 25-mm, 0.2-mm-pore polycarbonate membrane affixed to the sur-
face of CDMplus 1% agarose solid medium in a 100-mm petri dish. Plates were incubated for ;16 h at
37°C, and polycarbonate membranes were moved to unoccupied areas of the dish and further incu-
bated at 37°C for an additional 4 h. Membranes were then transferred to 1.5-ml microcentrifuge tubes
containing 1ml of RNAlater (Ambion) and vortexed until no visible cells remained attached to the mem-
brane surface. Cells were pelleted by centrifugation (2 min at 10,000 g), and supernatants and cell pel-
lets were stored for RNA purification. RNA purification and Affymetrix microarray preparations were per-
formed as described elsewhere (66, 67).
Array analyses were performed using RMA analysis through the University of Oklahoma Bioinformatics
Core Facility (http://www.ou.edu/microarray/). 2s analysis was used to determine the significant difference
of fold change with a 95% confidence interval. Significant fold changes were considered for values greater
than 3.4-fold for the rpoN mutant versus wild-type and greater than 1.8-fold for the complement versus
wild-type comparisons.
In silico analysis of identified proteins. Signal peptide sequences were predicted using SignalP 5.0
and SignalP-HMM algorithms (http://www.cbs.dtu.dk/services/SignalP-5.0/) (68). Transmembrane domains
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were predicted using TMHMM (hidden Markov model) (http://www.cbs.dtu.dk/services/TMHMM/) (69) and
TMpred (transmembrane helix propensity scale) (https://embnet.vital-it.ch/software/TMPRED_form.html)
(70). LPXTG motifs were identified using PHI-BLAST and the pattern query for the sortase cell wall-sorting
signal (L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]) (25) with the E. faecalis collagen adhesion protein, Ace, as a
template query (26). Lipoprotein predictions were conducted using Pred-Lipo software (http://www
.compgen.org/tools/PRED-LIPO) (71). Default settings for Gram-positive bacteria were used in all cases.
Quantitative real-time PCR. Synthesis of cDNA was performed using SuperScript III reverse tran-
scriptase (Life Technologies) from 1mg of DNase-treated (Ambion Turbo DNase) RNA templates follow-
ing the manufacturer’s instructions (Zymo Research). Random hexamer primers (Invitrogen) were used
in the initial synthesis reaction. The primers used in quantitative real-time PCR (qRT-PCR) analysis are
listed in Table S2. The qRT-PCR was performed with 1mg of prepared cDNA and 300 nM each primer
using PowerUp SYBR green master mix (Thermo Fisher Scientific) on a QuantStudio 3 real-time PCR sys-
tem (Thermo Fisher Scientific). Following denaturation at 95°C for 3 min, the qRT-PCR was set for 50
cycles with 95°C for 10 s, 60°C for 20 s, and 72°C for 10 s. Differential gene expression was calculated
using the threshold cycle (DDCT) method using the threshold cycle values for the gene of interest
(ef0019, ef2223, ef0891, ef1017, ef3210, and ef0255) and the endogenous control (ef0005 [gyrB]). Each
qRT-PCR experiment was repeated with three biological replicates.
Biofilm formation assessment using a drip-flow biofilm reactor. A drip-flow biofilm reactor
(DFBR) was utilized as previously described (28, 29) to assess V583, DrpoN, DrpoN::rpoN, DccpA, and
DccpA::ccpA strains for their ability to form biofilms. Briefly, the channels of the growth chamber of the
DFBR were seeded with diluted overnight cultures grown in THB (1:100) in either MM9YEGC (G= 15mM
glucose) or MM9YEFC (F = 15mM fructose) medium and incubated at 37°C for 8 h to allow initial adher-
ence. Subsequently, 0.1 MM9YEGC or MM9YEFC medium was fed into the 10°-tilted growth chamber
of the DFBR by inlet valves and tubing at 125ml/min for 72 h. Biofilm enumeration was conducted, asep-
tically, by removing the glass slides and scraping the biofilm into a 50-ml conical test tube containing
5ml 1 phosphate-buffered saline (PBS). Homogenization of the biofilm was conducted using a Tissue-
Tearor homogenizer (BioSpec Products) with a 15-s pulse, followed by serial dilution and plating on THB
plates. The experiment was performed with three biological replicates.
Animal models. All of the procedures in the rabbit model to study experimental endocarditis and
murine model for catheter-associated urinary tract infection were performed in compliance with the
Animal Welfare Act and other federal statutes and regulations relating to animals and experiments
involving animals. All animal protocols were approved by the Institutional Animal Care and Use
Committee for Kansas State University (IACUC 3043, rabbit endocarditis) and (IACUC 3267, murine
CAUTI).
Experimental endocarditis and determination of bacterial burden. Left-sided endocarditis was
induced in New Zealand White rabbits (Charles River Laboratories International, Inc.) by introducing a
polyethylene catheter with an internal diameter of 0.86mm (Becton, Dickinson, MD), followed by injec-
tion of bacterial cultures (107 CFU; E. faecalis V583 [72] and DrpoN [6] strains) via marginal ear vein after
24 h of catheterization, as previously described (30). In preparation for injections, bacterial cultures
grown to the stationary phase were washed twice and diluted to achieve a concentration of 107 CFU/ml
in sterile saline. Groups of eight rabbits were injected with each bacterial strain (V583 and DrpoN), and
two negative controls were injected with sterile saline. The rabbits were monitored for 48 h after bacte-
rial inoculation and euthanized by intraperitoneal administration of sodium pentobarbital. Immediately
after euthanasia, a cardiac stick was performed to determine bacterial CFU in blood at the time of sacri-
fice. Bacterial burden in the heart, liver, spleen, and kidneys was assessed by plate count, following a
previously described protocol (30), and expressed as log10 CFU/g of tissue.
Murine model for catheter-associated urinary tract infection. The catheter-associated urinary
tract infection (CAUTI) model used 6- to 7-week-old female wild-type C57BL/6 mice. The mice were anes-
thetized by isoflurane inhalation, and a 5- to 6-mm platinum-cured silicone implant tube (Renasil Sil025;
Braintree Scientific, Inc.) was transurethrally placed in the urinary bladder of each mouse as previously
described (31). Postimplantation, the mice were injected with 50-ml inocula of either sterile PBS or bacte-
rial suspension (;2 107 CFU) by transurethral catheterization. The mice were monitored for 48 h post
implantation and infection. They were euthanized by cervical dislocation after inhalation of isoflurane.
To determine the degree of infection, kidneys and bladder were harvested aseptically, and their bacterial
burden was determined. Also, the silicone implant tubing was retrieved from the bladder and the bacte-
rial burden enumerated using THB medium.
Bioinformatics and statistical analysis. Catabolite-responsive element (cre) sites were identified
upstream of the differentially expressed genes using the pattern analysis option in Regulatory Sequence
Analysis Tools (http://rsat.ulb.ac.be/rsat/) and the cre consensus from Schumacher et al. (13)
(WTGNNARCGNWWWCAW), as well as that from Miwa et al. (WTGWAARCGYWWWCW) (12), allowing for
a 1-bp mismatch. The statistical analysis of the various growth curves performed were measured using a
one-way analysis of variance (ANOVA) test. The statistical analysis of the bacterial burden determined in
the various organs in the endocarditis study and CAUTI was performed using GraphPad Prism 5 software
(San Diego, CA). Statistical significance was measured using a nonparametric t test (Mann-Whitney test).
Data availability. Raw array data have been deposited in the NCBI Gene Expression Omnibus
(https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE40237.
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